GeneDx (WGS) Insider Trading & Ownership $69.38 -1.66 (-2.34%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GeneDx (NASDAQ:WGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage27.30%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$4.12 MNumber OfInsiders Selling(Last 12 Months)19Amount OfInsider Selling(Last 12 Months)$103.45 M Get WGS Insider Trade Alerts Want to know when executives and insiders are buying or selling GeneDx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WGS Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin GeneDx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Katherine StuelandCEOSell22,307$70.34$1,569,074.38 11/18/2024School Of Medicine At Mo IcahnMajor ShareholderSell126,782$70.78$8,973,629.96 11/15/2024Katherine StuelandCEOSell23,108$70.48$1,628,651.84 11/15/2024School Of Medicine At Mo IcahnMajor ShareholderSell20,359$69.78$1,420,651.02 10/31/2024School Of Medicine At Mo IcahnMajor ShareholderSell865,800$75.00$64,935,000.00 10/29/2024Katherine StuelandCEOSell2,154$66.60$143,456.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/29/2024Kevin FeeleyCFOSell274$66.60$18,248.40 9/9/2024Katherine StuelandCEOSell3,639$33.33$121,287.87 9/9/2024Kevin FeeleyCFOSell895$33.33$29,830.35 9/3/2024Kevin FeeleyCFOSell262$31.71$8,308.02 8/19/2024Opko Health, Inc.Major ShareholderSell50,000$34.49$1,724,500.00 8/15/2024Opko Health, Inc.Major ShareholderSell39,824$33.08$1,317,377.92 8/12/2024Opko Health, Inc.Major ShareholderSell59,787$33.95$2,029,768.65 8/8/2024Opko Health, Inc.Major ShareholderSell100,000$31.82$3,182,000.00 8/6/2024Opko Health, Inc.Major ShareholderSell12,994$29.35$381,373.90 7/31/2024Opko Health, Inc.Major ShareholderSell88,839$33.50$2,976,106.50 7/29/2024Katherine StuelandCEOSell2,154$33.54$72,245.16 7/29/2024Kevin FeeleyCFOSell274$33.54$9,189.96 7/29/2024Opko Health, Inc.Major ShareholderSell50,000$33.86$1,693,000.00 7/26/2024Opko Health, Inc.Major ShareholderSell60,000$33.85$2,031,000.00 7/24/2024Opko Health, Inc.Major ShareholderSell75,000$33.72$2,529,000.00 7/22/2024Opko Health, Inc.Major ShareholderSell50,000$32.61$1,630,500.00 7/19/2024Opko Health, Inc.Major ShareholderSell25,000$32.29$807,250.00 7/17/2024Opko Health, Inc.Major ShareholderSell25,000$32.93$823,250.00 7/5/2024Opko Health, Inc.Major ShareholderSell36,118$28.24$1,019,972.32 7/3/2024Opko Health, Inc.Major ShareholderSell14,082$28.23$397,534.86 7/1/2024Opko Health, Inc.Major ShareholderSell50,000$26.63$1,331,500.00 6/17/2024Katherine StuelandCEOSell7,683$28.31$217,505.73 6/17/2024Kevin FeeleyCFOSell2,646$28.31$74,908.26 6/10/2024Katherine StuelandCEOSell2,652$24.92$66,087.84 6/10/2024Kevin FeeleyCFOSell895$24.92$22,303.40 6/3/2024Casdin Capital, LlcDirectorBuy100,000$20.82$2,082,000.00 5/28/2024Casdin Capital, LlcDirectorBuy18,304$20.61$377,245.44 5/23/2024Casdin Capital, LlcDirectorBuy7,500$19.59$146,925.00 5/13/2024Casdin Capital, LlcDirectorBuy50,000$23.31$1,165,500.00 4/29/2024Katherine StuelandCEOSell6,325$11.04$69,828.00 4/29/2024Kevin FeeleyCFOSell1,104$11.04$12,188.16 3/18/2024Kareem SaadInsiderSell2,008$10.59$21,264.72 3/18/2024Katherine StuelandCEOSell8,559$10.59$90,639.81 3/18/2024Kevin FeeleyCFOSell3,253$10.59$34,449.27 [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin3/4/2024Casdin Capital, LlcDirectorBuy40,000$8.74$349,600.00 1/22/2024Kareem SaadInsiderSell193$3.24$625.32 1/3/2024Kareem SaadInsiderSell105$2.58$270.90 12/18/2023Kareem SaadInsiderSell1,700$2.16$3,672.00 12/18/2023Katherine StuelandCEOSell11,734$2.16$25,345.44 12/18/2023Kevin FeeleyCFOSell2,948$2.16$6,367.68 12/4/2023Kevin FeeleyCFOSell270$1.77$477.90 (Data available from 1/1/2013 forward) WGS Insider Trading Activity - Frequently Asked Questions Who is on GeneDx's Insider Roster? The list of insiders at GeneDx includes Anthony Prentice, Casdin Capital, Llc, Daniel Emmett Clark, Eric Schadt, Isaac Ro, Jason Ryan, Kareem Saad, Karen Ann White, Katherine Stueland, Keith A Meister, Kevin Feeley, Opko Health, Inc., Richard C Pfenniger Jr, Richard Miao, School Of Medicine At Mo Icahn, Shawn Assad, and Tactical Opportunit Blackstone. Learn more on insiders at WGS. What percentage of GeneDx stock is owned by insiders? 27.30% of GeneDx stock is owned by insiders. Learn more on WGS's insider holdings. Which GeneDx insiders have been buying company stock? The following insiders have purchased WGS shares in the last 24 months: Casdin Capital, Llc ($4,121,270.44), Jason Ryan ($72,062.34), Katherine Stueland ($99,988.02), and Richard C Pfenniger Jr ($69,900.00). How much insider buying is happening at GeneDx? Insiders have purchased a total of 298,157 WGS shares in the last 24 months for a total of $4,363,220.80 bought. Which GeneDx insiders have been selling company stock? The following insiders have sold WGS shares in the last 24 months: Jason Ryan ($133.98), Kareem Saad ($40,107.60), Karen Ann White ($29,346.88), Katherine Stueland ($4,219,100.26), Keith A Meister ($2,715,741.60), Kevin Feeley ($282,910.97), Opko Health, Inc. ($23,874,134.15), and School Of Medicine At Mo Icahn ($75,329,280.98). How much insider selling is happening at GeneDx? Insiders have sold a total of 2,115,264 GeneDx shares in the last 24 months for a total of $106,490,756.42 sold. GeneDx Key ExecutivesMs. Katherine A. Stueland (Age 48)President, CEO & Director Compensation: $745.91k7 recent tradesMr. Kevin Feeley (Age 43)Chief Financial Officer Compensation: $488.19k6 recent tradesMs. Karen PonchnerSenior VP & Head of OperationsMr. Eric Olivares Ph.D.Chief Product & Technology OfficerMr. Devin K. Schaffer J.D.M.B.A., General CounselMr. Paul Kruszka M.D.Chief Medical OfficerMs. Melanie DuquetteChief Growth OfficerSabrina DunbarChief of Staff More Insider Trading Tools from MarketBeat Related Companies HIMS Insider Buying GH Insider Buying SHC Insider Buying OPCH Insider Buying BTSG Insider Buying VCYT Insider Buying SGRY Insider Buying LFST Insider Buying PACS Insider Buying PRVA Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:WGS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.